LSX Medtech Panelists Talk AI, Market Access Strategies, Digital Therapeutics Reimbursement

Highlights from Medtech Insight's on-the-ground coverage of LSX in Boston. 

LSX World
• Source: Citeline

Medtech Insight is on the ground at the LSX World Congress USA, which brings together leaders from medtech, healthtech and biotech and investors with a focus on facilitating partnerships, investment and dealmaking.

About 1,000 attendees from across the globe flocked to Boston 11-12 September to explore new opportunities, network and learn.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Digital Technologies

More from Medtech Insight

Dxcover Launches US Operations With New Headquarters In Tennessee

 

Dxcover sets up new Clinical Laboratory Improvement Amendments (CLIA) lab in Franklin, Tennessee.

EnsoData Boosts AI Sleep Tech With $20M Series B Funding, Targets Underdiagnosis Crisis

 
• By 

EnsoData positions itself as device-agnostic and interoperable, with FDA-cleared software that can integrate with all major devices. CEO Mortara said this flexibility helps maximize patient reach by enabling both direct provider engagement and integration with device manufacturers.

FDA Blocks Some Olympus Endoscopes From Entering US

 

After multiple warning letters and safety communications, the US FDA has decided to block the import of certain endoscopes from Olympus. In total, the agency’s action pertains to 58 device models manufactured by the Japanese firm used in urinary, respiratory, abdominal and pelvic procedures.